Enhancement of allergic inflammation by diesel exhaust particles: permissive role of reactive oxygen speciesCASILLAS, A. M; HIURA, T; NING LI et al.Annals of allergy, asthma, & immunology. 1999, Vol 83, Num 6, pp 624-629, issn 1081-1206, 2Conference Paper

Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: Use of an old method with a new productSTIEHM, E. R; CASILLAS, A. M; FINKELSTEIN, J. Z et al.Journal of allergy and clinical immunology. 1998, Vol 101, Num 6, pp 848-849, issn 0091-6749, 1Article

Contrasting effects of two tumour promoters, phorbol myristate acetate and okadaic acid, on T-cell responses and activation of p42 MAP-kinase/ERK-2AMARAL, M. C; CASILLAS, A. M; NEL, A. E et al.Immunology (Oxford). 1993, Vol 79, Num 1, pp 24-31, issn 0019-2805Article

Exploring alternative models of complex patient management with artificial neural networks = Explorer les modèles alternatifs de gestion complexe du patient avec un réseau neural artificielCASILLAS, A. M; CLYMAN, S. G; FAN, Y. V et al.Advances in health sciences education. 2000, Vol 5, Num 1, pp 23-41, issn 1382-4996Article

Okadaic acid activates p42 mitogen-activated protein kinase (MAP kinase; ERK-2) in B-lymphocytes but inhibits rather than augments cellular proliferation : contrast with phorbol 12-myristate 13-acetateCASILLAS, A. M; AMARAL, K; CHEGINI-FARAHANI, S et al.Biochemical journal (London. 1984). 1993, Vol 290, pp 545-550, issn 0264-6021, 2Article